Educational information, not medical advice — ask your doctor or midwife.
Taranjabin is a naturally occurring sweet exudate that oozes from the stems and pods of the camel thorn plant (Alhagi maurorum), a thorny shrub native to Iran, Afghanistan, and Central Asia. It has been a cornerstone remedy in Persian (Tibb) and Unani medicine for at least a thousand years, referenced in the Canon of Medicine by Ibn Sina (Avicenna) as a mild, child-friendly laxative and fever-cooling agent. The exudate hardens into small, amber-colored crystals or granules that are collected, dried, and used medicinally.
Taranjabin works through several complementary pathways. Its naturally occurring sugars and mucilage act as mild osmotic laxatives, drawing water into the bowel to soften stool and stimulate gentle movement. Its flavonoid compounds — particularly quercetin and isorhamnetin — contribute anti-inflammatory and antioxidant effects that may help cool systemic inflammation and support liver and bile function. The prebiotic oligosaccharides also feed beneficial gut bacteria, which supports overall digestive health.
The most traditional form is the raw dried crystalline exudate, dissolved in warm water or mixed into herbal decoctions. Powdered forms are available for encapsulation or blending. In Iranian traditional pharmacy, it is commonly prescribed as a syrup or dissolved granule preparation. Modern supplement presentations include capsules, though these are less common and less studied.
Taranjabin has been documented in Persian medical literature for over a millennium. Ibn Sina (Avicenna, 980–1037 CE) described it in the Canon of Medicine as a gentle, cooling laxative suitable for children and the elderly, and as a remedy for fever and bile disorders. It remains actively used in traditional Iranian medicine (TIM) today and is the subject of growing pharmacological and clinical research at Iranian universities.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.